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miR-155 has been confirmed to be a key factor in immune responses in humans and 
other mammals. Therefore, investigation of variations in miR-155 could be useful for 
understanding the differences in immunity between individuals. In this study, four SNPs 
in miR-155 were identified in mice (Mus musculus) and humans (Homo sapiens). In 
mice, the four SNPs were closely linked and formed two miR-155 haplotypes (A and 
B). Ten distinct types of blood parameters were associated with miR-155 expression 
under normal conditions. Additionally, 4 and 14 blood parameters were significantly 
different between these two genotypes under normal and lipopolysaccharide (LPS) 
stimulation conditions, respectively. Moreover, the expression levels of miR-155, the 
inflammatory response to LPS stimulation, and the lethal ratio following Salmonella 
typhimurium infection were significantly increased in mice harboring the AA genotype. 
Further, two SNPs, one in the loop region and the other near the 3′ terminal of pre-
miR-155, were confirmed to be responsible for the differential expression of miR-155 
in mice. Interestingly, two additional SNPs, one in the loop region and the other in 
the middle of miR-155*, modulated the function of miR-155 in humans. Predictions of 
secondary RNA structure using RNAfold showed that these SNPs affected the structure 
of miR-155 in both mice and humans. Our results provide novel evidence of the natural 
functional SNPs of miR-155 in both mice and humans, which may affect the expression 
levels of mature miR-155 by modulating its secondary structure. The SNPs of human 
miR-155 may be considered as causal mutations for some immune-related diseases 
in the clinic. The two genotypes of mice could be used as natural models for studying 
the mechanisms of immune diseases caused by abnormal expression of miR-155 in 
humans.
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inTrODUcTiOn
MicroRNAs (miRNAs) are small non-coding RNAs that inhibit 
the expression of specific target genes at the posttranscriptional 
level. Mature miRNAs are produced in a two-step sequential pro-
cess that involves the generation of pre-miRNA from pri-miRNA 
via processing by the Drosha/DGCR8 complex in the nucleus, 
followed by the generation of mature miRNAs from pre-miRNAs 
via processing by the Dicer/TRBP complex in the cytoplasm. 
Sequence variations in pri-miRNAs, pre-miRNAs, and mature 
miRNAs may have profound effects on miRNA biogenesis and 
function (1).
miR-155 is derived from the non-coding transcript of the 
proto-oncogene B-cell integration cluster (bic) and is highly 
expressed in activated B and T cells as well as active macrophages 
and dendritic cells (DCs) (2). Many studies have confirmed that 
miR-155 plays important roles in the development and activation 
of immune-related cells. Overexpression of miR-155 in normal 
human CD34+ peripheral blood stem cells (PBSCs) significantly 
inhibited the generation of myeloid and erythroid colonies (3). In 
miR-155-deficient mice, the number of natural killer cell is signifi-
cantly reduced compared with wild-type mice (4). Additionally, 
the amount of IgG1 produced by B cells following stimulation 
with lipopolysaccharide (LPS) and interleukin 4 (IL-4) was 
significantly reduced by miR-155 deficiency (4). Moreover, Th2 
polarization and Th2 cytokine levels were significantly increased 
in CD4+ T cells derived from miR-155-deficient mice (4, 5). 
Fewer Th17 and Th1 cells were present in the spleen and lymph 
nodes under experimental autoimmune encephalomyelitis in 
miR-155-deficient mice (6). miR-155-deficient DCs failed to effi-
ciently present antigens (4). The abundance of T regulatory cells 
was significantly reduced in the thymus, spleen, and lymph nodes 
of miR-155-deficient mice (7). In addition, miR-155 deficiency 
impairs CD8+ T cell proliferation (2), and miR-155 is essential for 
promoting the clonal expansion, survival, and memory genera-
tion behavior of CD8+ T cells during antiviral and antibacterial 
responses (8). Many target genes of miR-155 have been identified, 
and most of these genes are essential to hematopoietic develop-
ment. Previous studies have shown that miR-155 can directly 
repress the C/EBPβ, PU.1, SHIP1, Tab2, Ikbke, map3k14, and 
Bach1 genes (9–13). These studies indicate that miR-155 plays 
crucial roles in immune cell development and immune responses.
In this study, four SNPs were identified in humans and mice. 
The roles of these SNPs in miR-155 expression and the immune 
response were further investigated. Two functional SNPs were 
identified in both humans and mice; these SNPs were responsible 
for altering the expression levels of mature miR-155 and modulat-
ing miR-155-mediated immune responses. Our findings provide 
new evidence of the functional SNPs of miR-155 and their effects 
on miR-155-regulated immune responses.
MaTerials anD MeThODs
animals
C57BL/6 and Kunming mice were purchased from the Center 
for Disease Control of Hubei Province, China. The animals were 
housed five per cage at room temperature, with a 12-h light/
dark cycle and free access to water and food. This study used 
5- to 6-week-old mice. The experiments were performed in 
accordance with the Guide for the Care and Use of Laboratory 
Animals (14), and the protocols received approval from the 
Hubei Province Committee on Laboratory Animal Care 
(HZAUMU2013-0005).
lPs administration and Salmonella 
typhimurium infection
Purified LPS extract from S. typhimurium (Sigma, L6511) was dis-
solved in sterile phosphate-buffered saline (PBS) at 1 mg/ml and 
frozen in aliquots at −20°C. Animals were administered LPS via 
intraperitoneal injection at 10 mg/kg according to previous stud-
ies (15–17). Animals were infected with 5 × 106 colony-forming 
units (CFU) of S. typhimurium via intraperitoneal injection.
identification of miR-155 Polymorphisms
For identification of polymorphism in human miR-155, the 
data of 1,000 genome sequence were examined (18, 19). Four 
candidate SNPs in the pre-miR-155 were selected for functional 
evaluation. In mice, the 256-bp DNA fragment containing the 
mature miR-155 sequence was amplified using DNA samples 
from C57BL/6 and Kunming mice. Polymerase chain reaction 
(PCR) was performed in 10-μl reactions containing 10 ×  PCR 
buffer, 0.3 μM of each primer, 75 μM of dNTPs, 1 U of Taq DNA 
polymerase (Takara Biotechnology), and 50 ng of mouse genomic 
DNA. The PCR cycling conditions were 5 min at 94°C, followed 
by 36 cycles of 30 s at 94°C, 30 s at 60°C, and 20 s at 72°C and a 
final extension step of 5 min at 72°C. The polymorphisms were 
identified based on the sequencing results. Ultimately, four SNPs 
were identified in mice, and these SNPs were closely linked and 
formed two haplotypes.
analysis of the associations 
of hematological Parameters
A total of 552 mice from 53 crosses (AB × AB) were used for cor-
relation analysis. Because one of the SNPs in the haplotype could 
be detected using the restriction enzyme StuI, the genotype of the 
population was determined using the PCR-restriction fragment 
length polymorphism (RFLP) method. For phenotype detection, 
peripheral blood from each mouse at 5–6 weeks of age was col-
lected into an anticoagulant vacuum blood tube. A total of 24 
blood parameters were measured using a hematological analysis 
system (Sysmex XT-2000i, Sysmex, Japan); the tested parameters 
included white blood cell count (WBC), absolute neutrophil 
count (NEUT), absolute lymphocyte count (LYMPH), absolute 
monocyte count (MONO), absolute eosinophil count (EO), abso-
lute basophil count (BASO), neutrophil percentage (NEUTp), 
lymphocyte percentage (LYMPHp), monocyte percentage 
(MONOp), eosinophil percentage (EOp), basophil percentage 
(BASOp), red blood cell count (RBC), hemoglobin concentra-
tion (HGB), hematocrit (HCT), mean cell volume (MCV), mean 
corpuscular hemoglobin (MCH), mean corpuscular hemo-
globin concentration (MCHC), red cell distribution width-SD 
(RDW-SD), red cell distribution width-CV (RDW-CV), platelet 
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count (PLT), plateletcrit (PCT), mean platelet volume (MPV), 
platelet distribution width (PDW), and platelet-large cell ratio 
(PLCR). Moreover, 52 and 43 mice harboring the AA and BB 
genotype, respectively, were selected for analysis of the variations 
in blood parameters in response to LPS treatment. The mice were 
intraperitoneally injected with 10 mg/kg LPS. After 8 h of LPS 
stimulation, hematological parameters were measured. Analysis 
of the associations between genotypes and blood parameters was 
performed using the following GLM model in SAS (SAS Institute, 
Inc., Cary, NC, USA): Y = genotype + sex + e; sex was considered 
as a fix effect in this model.
northern Blotting
For northern blotting analysis, total RNA was extracted using 
TRIzol reagent according to the manufacturer’s protocol 
(Invitrogen, USA). From 15 to 30 μg of total RNA was electro-
phoretically separated on a 15% polyacrylamide denaturing gel. 
The total RNA was then transferred to a Hybond-N+ membrane 
(Amersham Biosciences, UK) using a semidry Transblot electro-
phoresis apparatus (Bio-Rad, USA). The RNA was fixed to the 
membrane by heating the membrane in the oven at 80°C for 
30 min and then cross-linked to the membrane via UV irradiation. 
Hybridization was performed using PerfectHyb™ Hybridization 
Solution according to the manufacturer’s protocol (Toyobo, 
Japan). The hybridization probe sequence was complementary to 
the mature form of miR-155 (Table S1 in Supplementary Material) 
and was labeled with γ-32P. After washing, the membranes were 
imaged using a phosphor imager (Bio-Rad, USA). U6 was used 
as a control and was detected in a manner similar to miR-155. 
The signals of the northern blotting bands were quantified using 
Quantity One software (Bio-Rad, USA).
Tissue sections
Spleen, lung, and liver tissues were collected from Kunming mice 
harboring the AA or BB genotype following LPS treatment or 
no treatment. After 24 h of fixation, the spleen, lung, and liver 
tissues were dehydrated and embedded in paraffin wax. Then, 
4-μm tissue sections were sliced using a microtome (Leica 
Microsystems Nussloch GmbH, Nussloch, Germany), mounted 
on poly-lysine-coated slides (Boster, Wuhan, China), and 
stored at 4°C until staining. Afterward, the sections were depar-
affinized in xylene, rehydrated in a graded ethanol series, and 
stained with hematoxylin and eosin. Finally, the sections were 
mounted using neutral gum. Staining was examined via light 
microscopy (Olympus BX51, Tokyo, Japan).
enzyme-linked immunosorbent assay
To compare the cytokine levels between the two genotypes, we 
first collected serum from peripheral blood. In brief, whole blood 
from the eye socket of each mouse was collected into clean tubes. 
The tubes were then placed at an angle of 45° to 60° and incubated 
for 1 h at 37°C. Then, the tubes were centrifuged at 3,000 rpm 
for 5 min at room temperature. The supernatant was transferred 
to a new tube and centrifuged further at 12,000 rpm for 2 min 
at room temperature. Then, the purified supernatant was stored 
at −80°C. For cytokine (IL1β, TNFα, IL6, and IL8) detection, 
mouse ELISA kits were used, and all of the experimental steps 
were performed strictly according to the manufacturer’s protocol 
(NeoBioscience, Guangzhou, PR China). The fluorescence at 
450  nm was measured using a microplate reader (iMark, Bio-
Rad, USA). The concentration of each cytokine present in the 
samples was calculated in reference to a standard curve that was 
constructed using recombinant cytokines provided with each kit.
rna-seq analysis
Total RNA was obtained from spleen tissues after 0, 4, and 8 h of 
LPS treatment using TRIzol reagent (Invitrogen, USA). For each 
genotype, equal amounts of RNA from three individuals at each 
time point were pooled together. Ultimately, six RNA libraries 
were generated, and RNA-seq was performed by a commercial 
service (Genergy Biotechnology, Shanghai, PR China). The 
mRNA sequencing data were analyzed using Bowtie, TopHat, 
and Cufflinks (20). The reference genome version was GRCm38/
mm10.
Quantitative Pcr
After determining the RNA concentrations, reverse transcription 
was performed using a RevertAid First Strand cDNA Synthesis 
Kit (MBI Fermentas). For quantitative PCR (Q-PCR) analysis 
of miR-155, stem–loop RT primers were designed according to 
a previous report (21). Q-PCR was performed using a standard 
SYBR Green PCR kit (Toyobo, Japan) in a LightCycler 480 ther-
mal cycler (Roche, Switzerland). The PCR protocol was 2 min at 
95°C followed by 40 cycles of amplification (30 s at 95°C, 30 s at 
the annealing temperature, and 30 s at 72°C). Melting curves were 
obtained by increasing the temperature from 58 to 95°C at 0.5°C/s 
and then holding for 10 s. The U6 or tubulin gene was used as an 
internal control for the genes expression of miR-155, SHIP1, and 
PU.1. PCR was performed at least in triplicate, and relative gene 
expression levels were calculated using an optimized comparative 
Ct (ΔΔCt) method. The primers used for Q-PCR detection are 
listed in Table S1 in Supplementary Material. The significance of 
the differences in gene expression was analyzed using a t-test.
Western Blotting
To confirm the differential protein expression of the two impor-
tant hematopoietic-related miR-155 target genes between the 
two genotypes of mice, spleen tissue extracts were fractionated 
according to molecular weight via sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and then trans-
ferred to a polyvinylidene difluoride (PVDF) membrane using 
a semidry transfer apparatus (Bio-Rad, USA). Western blotting 
was performed using the following antibodies: anti-PU.1 (9G7), 
anti-SHIP1 (D1163), anti-GAPDH (14C10), and horseradish 
peroxidase (HRP)-conjugated anti-rabbit IgG (Cell Signaling 
Technology, USA). All of the antibodies were diluted 1,000-fold. 
The signal of the western blotting bands was quantified using 
ImageJ software (National Institutes of Health, USA).
Dna construction of Different miR-155 
snPs
The 256-bp mouse miR-155 expression cassette containing the 
entire pre-miR-155 sequence and partial flanking regions was 
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inserted into the 3′ untranslated region (UTR) of the green fluores-
cent protein (GFP) gene in the pEGFP-C1 vector (BD Biosciences 
Clontech, USA). The two haplotypes (A and B) and seven mutant 
constructs (M1–M7) were produced and were labeled as pEGFP-
C1-A/B/M1–M7. The 255-bp human miR-155 fragments were 
inserted into the 3′UTR of the GFP gene as performed on mouse 
miR-155. The normal and four mutant constructs of human 
miR-155 gene were generated and were labeled as pEGFP-C1-h 
or pEGFP-C1-h1–4, respectively. For the luciferase assay, the 
3′UTR fragments of the human and mouse Tab2, Bach1, Ikbke, 
and Map3k14 genes were inserted into the psi-check2 vector. The 
inserted fragments contained the validated miR-155 binding sites 
located at the 3′UTR of the respective target genes.
cell culture and Transfection
BHK-21 cells were cultured in complete Dulbecco’s modified 
eagle medium (DMEM) containing 10% fetal bovine serum 
(FBS) in a humidified incubator in 5% CO2 at 37°C. The different 
constructs were transfected at equal plasmid DNA concentrations 
into BHK-21 cells at 80–90% confluence. For analysis of miR-155 
expression in  vitro, the pEGFP-C1-A, pEGFP-C1-B, pEGFP-
C1-M1–M7, and pEGFP-C1 empty constructs were transfected 
into BHK-21 cells at equal plasmid DNA concentrations. For 
the luciferase activity assay, equal amounts of the pEGFP-C1-A, 
pEGFP-C1-B, pEGFP-C1-h, and pEGFP-C1-h1–4 constructs 
were co-transfected with one of the psi-check2-Tab2/Bach1/
Ikbke/Map3k14 vectors into BHK-21 cells.
statistical analysis
All data are presented as the means ± SEM. Significant differences 
between groups were determined using a t-test or analysis of 
variance (ANOVA). A P-value <0.05 was considered to indicate 
a statistically significant difference, and a P-value <0.01 was 
considered to indicate an extremely significant difference.
resUlTs
identification of miR-155 snPs in Mice 
and humans
In mice, a 256-bp genomic fragment of miR-155 was amplified 
using DNA samples from non-biologically related Kunming 
(n = 25) and C57BL/6 mice (n = 20). The sequencing results for 
the different strains of mice revealed four SNPs in the 256-bp frag-
ment, which formed two haplotypes (Figure 1A, Supplementary 
Figure 1). Furthermore, Kunming mice harbored the AA/AB 
and BB genotypes, but C57BL/6 mice harbored only the BB 
genotype. The secondary structures of miR-155 containing differ-
ent SNPs were predicted using mfold (http://unafold.rna.albany.
edu/?q=mfold). According to these results, two SNPs in miR-155, 
one in the loop region of miR-155 and the other near the 3′ end of 
pre-miR-155, influenced the secondary structure of pre-miR-155 
in mice (Figure  1B). In humans, according to results of 1,000 
human genomic sequence, four SNPs located in the pre-miR-155 
regions were identified (Figure 2A, Supplementary Figure 2). The 
first SNP was located in the mature miR-155 region, the second in 
the stem–loop regions of miR-155, and the third and the fourth 
in the miR-155* region. Of these four SNPs, only the third SNP 
changed the secondary structure of pre-miR-155 (Figure 2B).
Blood Parameters significantly Differed 
between the aa and BB genotypes of 
Kunming Mice
To explore the differences in the functions of the two haplotypes, 
a trait association study was first performed. Because the second 
mutation site of the haplotype could be detected using the restric-
tion enzyme StuI (GGCC), the genotypes of 552 Kunming mice 
were identified using the PCR–RFLP method. The results of the 
trait association analysis revealed that the A/B haplotype was sig-
nificantly associated with 10 different blood parameters. Among 
them, the WBC, NEUT, LYMPH, and HGB were significantly 
increased in the AA genotype compared with the BB genotype 
(P <  0.05) (Figure  3A, Table S2 in Supplementary Material). 
Following LPS treatment, 14 blood parameters were significantly 
different between the A and B haplotypes. The mean BASO, 
MONO, EO, BASOp, MONOp, and EOp values were increased 
in BB genotype mice (P < 0.05). The mean values of HGB, HCT, 
MCV, MCH, PLT, PCT, MPV, and PLCR were significantly 
increased in AA genotype mice (P < 0.05) (Figure 3B, Table S3 in 
Supplementary Material). In both AA and BB genotype mice, 18 
different blood parameters were significantly altered in response 
to LPS treatment compared with the corresponding untreated 
control mice. Among them, BASOp, NEUTp, MONOp, BASO, 
MCV, PDW, MPV, and PLCR were significantly increased in 
response to LPS stimulation compared with the control treatment 
among both AA and BB genotype mice (P < 0.05). In addition, 
the mean values of WBC, LYMPH, LYMPHp, RBC, HGB, HCT, 
MCHC, RDW-CV, PLT, and PCT were significantly reduced 
following LPS treatment in both genotypes of mice (P <  0.05) 
(Figure 3C).
aa genotype Kunming Mice exhibit 
stronger inflammatory responses than 
BB genotype Kunming Mice
Mice harboring the two genotypes were administered 10 mg/kg 
LPS via intraperitoneal injection. Splenomegaly symptoms were 
noted at 8 h after LPS injection (Figure 4A). The characteristics 
of the tissues were analyzed using histological analysis. Increased 
red pulp and reduced white pulp proportions were noted in 
the spleen tissue of the AA genotype mice compared with the 
BB genotype mice 8 h after LPS injection (Figure 4B). In the 
lung tissue, the alveolar wall was thicker in the AA genotype 
mice than in the BB genotype mice at 8 h of LPS stimulation 
(Figure 4C). Liver congestion and inflammatory cell infiltration 
symptoms were more serious in the AA genotype mice than in 
the BB genotype mice at 8 h of LPS stimulation (Figure 4D). We 
also performed TUNEL assays to compare the injury to these 
two genotype mice under LPS treatment. Our results showed 
that the proportion of apoptotic cells in the spleen and liver tis-
sues of AA genotype mice was significantly higher than that of 
BB genotype mice after LPS stimulation for 8 h (Supplementary 
Figures 3A–C). The ELISA results revealed increased IL1β, 
TNFα, IL6, and IL8 levels upon LPS treatment. The IL1β, TNFα, 
FigUre 1 | identification of the two haplotypes of the mouse miR-155 gene and the corresponding secondary rna structures. (a) Schematic diagram 
of the SNP sites and sequences of the A and B haplotypes of the mouse miR-155 gene. (B) Prediction of the secondary RNA structures of miR-155 for the two 
haplotypes using mfold tools. The left image represents the A haplotype, and the right image represents the B haplotype. The SNP sites are highlighted in bright 
yellow. The mature miR-155 sequences are highlighted in bright red. The secondary structure of the stem–loop and the Drosha digestion site are magnified.
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and IL6 levels in AA genotype mice were significantly increased 
compared with BB genotype mice at 8 or 4 h of LPS exposure 
(Figures 4E–H). RNA-seq data from the spleen tissues showed 
that the transcriptional levels of all the detectable inflammation 
related cytokines were up-regulated after 4 or 8 h of LPS treat-
ment. Moreover, the IL1β, TNFα, IL6, IL1α, IL18, CCL4, CCL5, 
and CCL3 genes were relatively higher in spleen tissues from 
the AA genotype mice than in those from the BB genotype mice 
at 0 h. While the transcriptional levels of CXCL11, IL10 and 
IL12b genes were relatively lower in spleen tissues from the AA 
genotype mice at 0 h. However, for all the genes, not much dif-
ference were found at mRNA level between AA and BB genotype 
mice at 4 or 8 h of LPS exposure (Supplementary Figure 3D). 
Further, the AA genotype mice exhibited significantly reduced 
survival time after infection with S. typhimurium compared with 
the BB genotype mice (P < 0.05) (Figure 4I). All of these results 
indicated that the inflammatory response was stronger in the 
AA genotype mice than in the BB genotype mice following LPS 
treatment or pathologic infection.
The expression level of miR-155 is 
increased in aa genotype Kunming Mice 
compared With BB genotype Kunming 
Mice
The expression levels of miR-155 in the spleen and lung were 
detected by northern blotting. The results showed that miR-155 
was upregulated sharply, reaching its highest level at 8 h of LPS 
exposure, and then declined to approximately the normal level 
at 24 h of LPS exposure in the spleen and lung tissues. The trend 
of miR-155 expression following LPS treatment was similar in 
between AA and BB genotype mice (Figures 5A,B). Moreover, 
miR-155 expression in spleen tissue of AA genotype mice was 
approximately 1.5- to 2-fold higher than that of BB genotype mice 
FigUre 2 | identification of snPs of the human miR-155 gene and the corresponding secondary rna structures. (a) Schematic diagram of the SNP 
sites and sequences of the human miR-155 gene. (B) Prediction of the secondary RNA structures of human miR-155 for the different SNPs using mfold tools. The 
SNP sites are highlighted in bright yellow. The mature miR-155 sequences are highlighted in bright red.
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at 0 and 8 h of LPS exposure. Additionally, miR-155 expression in 
the lung tissue was significantly increased in AA genotype mice 
compared with BB genotype mice at 0 and 8 h of LPS exposure 
(Figures 5C–H). These results indicated that miR-155 was rapidly 
upregulated under LPS treatment, and that AA genotype mice 
exhibited increased miR-155 expression compared with BB 
genotype mice under both LPS treatment and non-treatment 
conditions.
The expression levels of the Majority of 
miR-155 Target genes in the spleen 
Tissue Were reduced in aa genotype 
Kunming Mice compared With BB 
genotype Kunming Mice
To further analyze the difference in miR-155 expression 
between the AA and BB genotypes, we analyzed the expression 
profiles of its target genes. Equal volumes of RNA from three 
individuals harboring each genotype who were exposed to LPS 
for 0, 4, or 8 h were pooled together, and the expression pro-
files of miR-155 target genes were predicted using TargetScan 
software and were determined using RNA-seq. The results 
showed that 76.99% (174 genes), 73.01% (165 genes), and 
58.85% (133 genes) of the target genes were downregulated in 
AA genotype mice compared with BB genotype mice at 0, 4, 
and 8  h of LPS exposure, respectively (Figures  6A–C, Table 
S5 in Supplementary Material). These results indicated that 
most of the miR-155 target genes were downregulated at 0 
and 4 h of LPS exposure in the AA genotype mice compared 
with the BB genotype mice. We further analyzed the signaling 
pathways regulated by the 20 downregulated miR-155 target 
genes [fold-change (FC) ≥ 1.2] at 4 h of LPS exposure using the 
Kyoto Encyclopedia of Genes and Genomes (KEGG) database 
(Figure  6E). The results showed that the TCR, BCR, MAPK, 
FigUre 3 | Blood parameters in Kunming mice were significantly 
different between the two genotypes with or without lPs treatment. 
(a) Trait association analysis indicated that 10 blood parameters were 
associated with the haplotypes of the mouse miR-155 gene (n = 552; 
AA = 148; AB = 222; BB = 182). Among these blood parameters, four 
(WBC, NEUT, LYMPH, and HGB) were significantly increased in AA genotype 
mice compared with BB genotype mice under normal conditions. (B) A total 
of 14 blood parameters were significantly different between the AA and BB 
genotype mice after 8 h of LPS exposure (n = 95; AA = 52, and BB = 43). 
Among these blood parameters, six (BASOp, MONOp, BASO, MONO EO, 
and EOp) were significantly increased in BB genotype mice, and eight (HGB, 
HCT, MCV, MCH, PLT, PCT, MPV, and PLCR) were significantly decreased in 
BB genotype mice under 8 h after LPS treatment. (c) A total of 18 blood 
parameters were significantly different at 8 h of LPS exposure compared with 
0 h (without LPS treatment) in both the AA and BB genotype mice (n = 425; 
at 0 h/non-treatment: AA = 148, BB = 182; at 8 h of LPS exposure: 
AA = 52, BB = 43). Among these blood parameters, 8 (BASO, NEUTp, 
MONOp, BASOp, MCV, PDW, MPV, and PLCR) were significantly increased 
after 8 h LPS exposure, and 10 (WBC, LYMPH, LYMPHp, RBC, HGB, HCT, 
MCHC, RDW-CV, PLT, and PCT) were significantly decreased at 8 h after  
 
LPS treatment compared to 0 h (without LPS treatment). WBC, white blood  
cell count; NEUT, absolute neutrophil count; LYMPH, absolute lymphocyte 
count; MONO, absolute monocyte count; EO, absolute eosinophil count; 
BASO, absolute basophil count; NEUTp, neutrophil percentage; LYMPHp, 
lymphocyte percentage; MONOp, monocyte percentage; EOp, eosinophil 
percentage; BASOp, basophil percentage; RBC, red blood cell count; HGB, 
hemoglobin concentration; HCT, hematocrit; MCV, mean cell volume; MCH, 
mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin 
concentration; RDW-SD, red cell distribution width-SD; RDW-CV, red cell 
distribution width-CV; PLT, platelet count; PCT, plateletcrit; MPV, mean 
platelet volume; PDW, platelet distribution width; PLCR, platelet-large cell 
ratio. *P < 0.05; **P < 0.01.
(Continued)
FigUre 3 | continued
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insulin, and Wnt pathways as well as various cancer signaling 
pathways were targeted by miR-155 (Figure  6D, Table S4 in 
Supplementary Material).
Protein levels of Two important miR-155 
Target genes significantly Differed 
between the Two genotypes of Kunming 
Mice
To further confirm the differential expression of miR-155 between 
the two genotypes of mice, we measured the protein expression 
of two miR-155 target genes, SHIP1 and PU.1, which are closely 
related to hematopoiesis. The protein levels of these two genes in 
the spleen tissue were significantly reduced in AA genotype mice 
compared with BB genotype mice at 0 and 8 h of LPS exposure 
(P < 0.05) (Figures 7A–D). Additionally, the mRNA levels of the 
SHIP1 and PU.1 genes were detected using Q-PCR. The results 
revealed a non-significant pattern of downregulated expression 
of these two genes in AA genotype mice compared with BB 
genotype mice (Figures 7E,F).
The expression levels and Functions of 
miR-155 Varied according to its snPs
To further confirm the differential expression of miR-155 between 
the A and B haplotypes in mice, we cloned the 256-bp DNA 
fragment that contained the entire pre-miR-155 sequence into 
the pEGFP-C1 vector. The constructed A and B haplotype vec-
tors were labeled pEGFP-C1-A and pEGFP-C1-B, respectively. 
The two constructs were transfected into BHK-21 cells at equal 
plasmid DNA concentrations. Then, the expression levels of pre-
miR-155 and mature miR-155 were detected by northern blotting. 
The expression of pre-miR-155 and mature miR-155 from the A 
haplotype construct was significantly higher by approximately 
1.5-fold than their expression from the B haplotype construct 
(P <  0.05) (Figures  8A,B). Moreover, the Q-PCR results con-
firmed that miR-155 expression from the A haplotype construct 
was significantly higher than that from the B haplotype construct 
(P  <  0.05) (Figure  8C). In addition, the dual-luciferase assay 
results indicated that both the A and B haplotype constructs 
inhibited the expression of the miR-155 target genes Tab2, Bach1, 
Ikbke, and Map3k14. Moreover, the A haplotype construct had 
a significantly stronger effect than the B haplotype construct 
(P <  0.05) (Figure 8D). In vitro experiments indicated that the 
FigUre 4 | The inflammatory response in the aa genotype Kunming mice was stronger compared with BB genotype Kunming mice. (a) The weight of 
the spleen was significantly increased at 8 h of LPS exposure compared with non-treatment. (B–D) Hematoxylin and eosin (H&E) staining of spleen, lung, and liver 
tissues at 0 and 8 h of LPS stimulation. Spleen tissue: scale bar = 100 μm; lung and liver tissues: scale bar = 50 μm. (e–h) The serum IL1β, TNFα, IL6, and IL8 
levels were detected via ELISA. These cytokines were upregulated by LPS treatment, and the levels of IL1β, TNFα, and IL6 were significantly increased in the AA 
genotype mice compared with the BB genotype mice (P < 0.05). The results are presented as the means ± SEM (n = 3). (i) The Kaplan–Meier survival curves of the 
AA genotype mice (n = 57) and the BB genotype mice (n = 41) were significantly different. The survival ratio of the BB genotype mice under infection of  
S. typhimurium was significantly higher than that of the AA genotype mice (P < 0.05). *P < 0.05; **P < 0.01.
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A haplotype construct generated more mature miR-155 than the 
B haplotype construct.
The 255-bp human DNA fragments, including the SNP sites 
of miR-155, were inserted into the pEGFP-C1 vector; the result-
ing constructs were labeled as pEGFP-C1-h/h1/h2/h3/h4. The 
dual-luciferase assay results indicated that the pEGFP-C1-h/h1/
h2/h3/h4 constructs inhibited the expression of the human miR-
155 target genes Tab2, Bach1, Ikbke, and Map3k14. Notably, the 
pEGFP-C1-h2 and pEGFP-C1-h3 constructs had significantly 
weaker effects on these four miR-155 target genes than pEGFP-
C1-h (P < 0.05). However, the other two constructs did not have 
clear effects on the expression of these four miR-155 target genes 
(Figure 8E).
Two snPs in the miR-155 haplotype 
affected miR-155 expression in Mice
To further explore whether functional SNPs in the haplotype 
contributed to the different expression levels of the mouse miR-
155 gene, we designed a series of mutant constructs (M1–M7). 
In these constructs, SNPs in the A haplotype were converted to 
the corresponding nucleotide in the B haplotype individually in 
constructs M1–M4. In M5, the two middle SNPs of the A hap-
lotype were converted to the corresponding nucleotide in the B 
haplotype synchronously. In M6 and M7, the two middle SNPs of 
the B haplotype were individually converted to the correspond-
ing nucleotide in A haplotype (Figure  9A). All of the mutant 
and normal A and B haplotype constructs were transfected into 
FigUre 5 | The expression of miR-155 was higher in aa genotype Kunming mice than in BB genotype Kunming mice. (a,B) Northern blotting was used 
to detect the expression of miR-155 in the spleen and lung tissues at 0, 4, 6, 8, 10, 12, and 24 h of LPS exposure. (c–F) Comparative analysis of the difference in 
miR-155 expression in the spleen and lung tissues at 0 and 8 h of LPS stimulation between the AA and BB genotype mice. (g,h) Quantitative analyses of the 
difference in miR-155 expression between the AA and BB genotype mice based on the northern blotting results using Quantity One software. The expression of 
miR-155 was significantly increased in the AA genotype mice compared with the BB genotype mice (P < 0.05). The expression of miR-155 was normalized to that 
of U6, and the results are presented as the means ± SEM (n = 5). *P < 0.05; **P < 0.01.
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BHK-21 cells at equal plasmid DNA amounts (Figure 9B). The 
expression level of miR-155 was detected by northern blotting 
24 h after transfection. The expression of miR-155 from the M1 
and M4 constructs was similar to that from the A haplotype 
construct and was significantly increased compared with that 
from the B haplotype construct (Figures 9C,D). The expression 
of miR-155 from the M2, M3, and M5 constructs was significantly 
reduced compared with that from the A haplotype construct 
(Figures 9E,F). The expression of miR-155 from the M6 and M7 
constructs was significantly increased compared with that from 
the B haplotype construct but was slightly reduced compared with 
that from the A haplotype construct (Figures 9G,H). The results 
of this point mutation analysis confirmed that the two middle 
SNPs contributed to the differential expression of the mouse miR-
155 gene between the A and B haplotypes. The expression level 
of the mouse miR-155 gene decreased when these two SNPs of 
the A haplotype were converted to the corresponding nucleotide 
in the B haplotype and increased when these two SNPs of the B 
haplotype were converted to the corresponding nucleotide in the 
A haplotype.
DiscUssiOn
Previous studies confirmed that miR-155 plays crucial roles in the 
immune response (22, 23). However, few studies have focused on 
its genetic variations. Notably, the miR-155 gene contains abun-
dant SNPs. In this study, we identified four SNPs in the 256-bp 
DNA fragment containing the miR-155 gene in mice. In fact, we 
detected 16 SNPs in a 1.2-kb DNA fragment in the Kunming and 
C57BL/6 mouse strains (data not shown). Additionally, four SNPs 
were identified in the human pre-miR-155 based on sequencing 
data for 1,000 human genomes. In total, 720 SNPs were found 
in the 15-kb human genomic DNA fragment containing miR-
155 (18, 19). The high mutation rates of miR-155 remind us of 
classic immune-related MHC genes. Previous studies reported 
that there were 86 SNPs per kb in the HLA-B gene (24, 25). The 
FigUre 6 | comparisons of the expression levels of miR-155 target genes in spleen tissue. (a–c) The dark line represents the expression levels of target 
genes in the BB genotype mice. The highest expression of the target gene in the BB genotype mice was normalized to one. All of the target genes were ranked 
from highest to lowest according to their expression levels in the BB genotype mice, and the corresponding target genes in the AA genotype mice are indicated by 
the red circle. The X-axis denotes the target gene, and the number indicates the rank of the target gene. The Y-axis is the standardized expression level of each 
target gene in the spleen tissues. The low-magnification figure contains all of the target genes, and several extremely highly expressed target genes were deleted 
from the high-magnification figure (D). The downregulated target genes in the AA genotype at 4 h of LPS exposure (FC ≥ 1.2) were used in KEGG pathway analysis. 
The X-axis indicates the number of target genes involved in each pathway. The Y-axis indicates the 11 significantly enriched signaling pathways related to these 
downregulated target genes. (e) List of the 20 downregulated target genes in the AA genotype mice at 4 h of LPS exposure (FC ≥ 1.2).
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high mutation rates of MHCs may be beneficial for the adaptive 
immunity of the host (26–28). Thus, we hypothesized that a high 
mutation rate of miR-155 may also be beneficial for the adaptive 
immunity of the host.
In mice, the four SNPs were closely linked and formed two 
haplotypes. The miR-155 levels were significantly different 
between these two haplotypes. Two SNPs, one located in the 
stem–loop and the other located near the 3′ end of pre-miR-155, 
were confirmed to be responsible for the differential expression 
of miR-155. Similarly, the middle two SNPs, especially the third 
SNP, weakened the effects of human miR-155 gene on all the tested 
target genes. We deduced that the middle two SNPs decreased 
the expression of mature miR-155 in humans. Bioinformatics 
analysis results showed that the RNA secondary structures of 
the Dicer/Drosha digestion sites of in pre-miR-155 were affected 
by these two SNPs in mice (Figure  1B). It is well known that 
mature miRNAs are processed by the RNA endonucleases Dicer 
and Drosha (29). Thus, we deduced that these two SNPs could 
affect the expression of miR-155 by interfering with RNA diges-
tion by Dicer or Drosha in mice. Previous studies also indicated 
that the expression level of miRNA could be influenced by SNPs 
located at Dicer/Drosha binding sites (30–32). The structure of 
human pre-miR-155 was changed by the third SNP according 
to the RNAfold results. Furthermore, the second SNP affected 
the function of the human miR-155 gene, although no evident 
structural variation was observed based on RNAfold analysis 
(Figure 2B). We deduced that the second SNP may have minor 
effects on the miRNA structure compared to the third SNP in 
humans. Correspondingly, the effects of the second SNP on the 
human miR-155 gene were weaker than the effects of the third 
SNP based on the dual-luciferase assay. Therefore, the SNPs, that 
cause variation in the secondary structures of pre-miRNA, may 
be important for the expression and functions of the correspond-
ing miRNAs.
The expression of miR-155 target genes differed between the 
two genotypes under normal and LPS stimulation conditions in 
mice. These results were consistent with the differential expres-
sion of miR-155 between the two genotypes. Moreover, we found 
in both genotypes that the differences in the expression of miR-
155 target genes peaked at 4 h of LPS exposure, and that these 
FigUre 7 | comparative analysis of the protein expression of miR-155 target genes in Kunming mice. (a,c) PU.1 and SHIP1 protein levels in the spleen 
tissues of mice at 0 and 8 h of LPS exposure were determined by western blotting. (B,D) Quantitative analysis of differential expression based on the western 
blotting results was performed using ImageJ software. (e,F) The mRNA levels of PU.1 and SHIP1 were detected using Q-PCR. Tubulin was used as an internal 
control. The results are presented as the means ± SEM (n = 4). *P < 0.05; **P < 0.01.
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differences nearly completely disappeared at 8 h of LPS exposure. 
One possible reason for this result may be that miR-155 expression 
reaches a very high level in both genotypes at 8 h of LPS exposure. 
Therefore, the genotype effects on the differential expression of 
miR-155 were reduced. In addition, pro-inflammatory and anti-
inflammatory factors regulate the balance of the inflammatory 
response (33–35). After a relatively long period of LPS exposure, 
many pro-inflammatory and anti-inflammatory factors may 
intervene in the expression of miR-155 target genes, which could 
also weaken the genotype effect on the differential expression 
of miR-155. In addition, we found that mice harboring the AA 
genotype of miR-155 have stronger inflammatory response under 
LPS treatment. The protein levels of inflammatory factors were 
significantly higher in AA genotype mice after LPS treatment via 
ELISA detection. Whereas, the mRNA level after LPS treatment 
did not show much difference between AA and BB genotype mice 
according to the RNA-seq data. We deduced the main reason was 
that the genes reached to the maximum transcriptional levels in 
AA genotype mice earlier than that in BB genotype mice, although 
the maximum level were almost same in these two genotype mice. 
Therefore, they could accumulate more proteins in AA genotype 
mice than in BB genotype mice.
miR-155 participates in the regulation of the development of 
many specific T lymphocyte subsets (2, 8, 36, 37). Few studies 
have focused on the regulation of blood parameters by miR-155. 
In Sus scrofa (pig), one SNP of miR-155 was associated with blood 
parameters (38). In this study, we also found that miR-155 was 
associated with various blood parameters in mice. No difference 
was found in body weight between the two genotypes. This finding 
indicated that the differences in miR-155 and blood parameters 
FigUre 8 | examination of the effects of different snPs in mouse and human miR-155 in vitro. (a,B) A 256-bp DNA fragment containing the entire mice 
pre-miR-155 sequence of the A or B haplotype was inserted into the pEGFP-C1 vector. The pEGFP-C1-A and pEGFP-C1-B constructs were then transfected into 
BHK-21 cells, and the expression of miR-155 was analyzed after 24 h. (c) Real-time PCR was performed to detect the expression of miR-155 after transfection of 
the pEGFP-C1-A/B construct. (D) A luciferase assay was used to analyze the expression of miR-155 in BHK-21 cells transfected with the pEGFP-C1-A or 
pEGFP-C1-B construct. The pEGFP-C1-A/B construct was co-transfected into BHK-21 cells with one of the psi-check2-mTab2/mBach1/mIkbke/mMap3k14 
constructs harboring the miR-155 binding site amplified from the 3′-untranslated region (UTR) of these four mouse genes. The luciferase activity was analyzed 24 h 
after transfection. The pEGFP-C1 empty vector was used as a negative control, and the luciferase activity of the pEGFP-C1-B-transfected cells was set to one. 
(e) A luciferase assay was used to analyze the functions of the human miR-155 gene in BHK-21 cells. A 255-bp DNA fragment containing human pre-miR-155, 
including the four SNPs of interest, was inserted into the pEGFP-C1 vector. One of the pEGFP-C1-h/h1/h2/h3/h4 constructs was co-transfected into BHK-21 cells 
with one of the psi-check2-hTab2/hBach1/hIkbke/hMap3k14 constructs harboring the miR-155 binding site amplified from the 3′-untranslated region (UTR) of these 
four human genes. The luciferase activity was analyzed 24 h after transfection. The pEGFP-C1 empty vector was used as a negative control, and the luciferase 
activity of the pEGFP-C1-h-transfected cells was set to one. U6 was used as an internal control for the expression of the mouse miR-155 gene. The results are 
presented as the means ± SEM (n = 3). *P < 0.05; **P < 0.01.
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were not influenced by body growth under normal conditions. 
However, the survival time was significantly different between the 
two mouse genotypes upon infection with S. typhimurium. These 
results indicated that the different expression levels of miR-155 
were not sufficient to affect growth under normal conditions but 
could cause observable phenotypic differences under pathologi-
cal conditions.
Moreover, miR-155 expression was rapidly altered by LPS 
stimulation. miR-155 was observably upregulated at 4 h of LPS 
exposure. Previous studies also found that miR-155 is rapidly 
upregulated by LPS, poly(I:C), or IFNβ treatment (17, 39, 40). 
Furthermore, we found that miR-155 expression began to decline 
at approximately 10  h of LPS exposure and had returned to 
normal levels at 24 h of LPS exposure. These results indicated 
that miR-155 degraded rapidly in the host. Other studies dem-
onstrated that upregulation of miR-155 could persist for greater 
than 24  h after LPS treatment in RAW 264.7 macrophages 
(41, 42); that finding was not consistent with our results. One 
possible reason for that finding may be that responses by RAW 
264.7 macrophages do not mimic in vivo responses, especially 
regarding the degradation of miRNA. Thus, we concluded that 
miR-155 acts during the acute phase of the immune response. 
Furthermore, according to our signaling pathway analysis, miR-
155 was involved in the TCR and BCR signaling pathways. The 
roles of miR-155 in these signaling pathways were confirmed 
in previous studies (4, 36, 40). We also found that miR-155 was 
involved in the MAPK, insulin, and Wnt signaling pathways. One 
previous study indicated that miR-155 was upregulated via the 
MAPK/NFκB signaling pathway in RAW 264.7 macrophages 
in response to stimulation with adiponectin (43). These results 
indicated that miR-155 can participate in the immune response 
by targeting numerous pathways.
Additionally, some studies indicated that certain mutations of 
miR-155 were associated with trisomy 21 (44), eczema (45), and 
FigUre 9 | Two important snPs in the haplotype can affect the expression of miR-155 in mice. (a) A schematic diagram of the mouse miR-155 gene 
SNPs. (B) BHK-21 cells were transfected with the pEGFP-C1-A/B/M1–M7 or pEGFP-C1 vector. (c,e,g) The expression of the mouse miR-155 gene from each of 
the pEGFP-C1-A/B/M1/M2/M3/M4/M5/M6/M7 constructs was detected by northern blotting. (D,F,h) Quantitative analysis of the expression levels of the mouse 
miR-155 gene based on northern blotting results was performed using Quantity One software. The pEGFP-C1 vector was used as a control. U6 was used as an 
internal control for the expression of the mouse miR-155 gene. The results are presented as the means ± SEM (n = 4). *P < 0.05; **P < 0.01.
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multiple sclerosis (46) in clinic. In our study, we found specific 
functional SNPs in human miR-155. Therefore, the mutations 
reported in this study may also relate to these diseases.
In conclusion, we identified two natural functional SNPs of 
miR-155 in both humans and mice. The miR-155 expression levels, 
blood parameters, and inflammatory responses differed between 
mice harboring different haplotypes. Moreover, we confirmed 
that two important SNPs in the haplotypes were responsible for 
the differential expression of miR-155 in mice. Moreover, these 
two SNPs affected the functions of human miR-155. Our study 
provides the first evidence that natural miR-155 SNPs can affect 
its expression and the host immune response.
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